TRINITY BIOTECH PLC reports a Return on Equity (ROE) of 67.15%.

What is TRIB's dividend yield?

TRINITY BIOTECH PLC offers a dividend yield of 0.00%.

What is TRIB's Deepscope Quality Score?

Deepscope rates TRIB's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy TRIB?

Deepscope's AI Timing Score for TRIB is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does TRIB belong to?

TRINITY BIOTECH PLC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.

Cổ phiếu TRIB (NASDAQ) | TRINITY BIOTECH PLC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-16 | FS: 2026-03-31)

TRIB

TRINITY BIOTECH PLC

US:NASDAQ STOCK Healthcare >> Medical Devices News 55

USD 0.57

-0.11 (-15.83%) Day Change

Watchlist Portfolio Compare Chart

-1.54

D/E

67.2%

ROE

-46.0%

ROA

0.00%

Div Yield

TRINITY BIOTECH PLC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.57 Price -0.11 (-15.83%) Day Change	NEWS SCORE: 55

TRIB Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 31) và Thời điểm mua ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROE là âm trong năm ngoái.
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	55
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.57
PBV / Sector	-0.19 / 7.45
Earning Per Share	-2.01

PE / Sector	N/A / 29.56
PEG or PE/Growth / Sector	N/A / 0.39
Average 1M Daily Value	0.13 M GREAT
Average 1W Daily Value	0.25 M GREAT

Yếu tố Kỹ thuật

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

58%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-99.16 / 20.12
NPM Average (%) / Sector	-68.80 / -15.01
NPM Change Average (%) / Sector	17.02 / 2.65 GOOD
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-45.96 / 11.02
ROA Average (%) / Sector	-39.46 / -0.05
ROA Change Average (%) / Sector	2.92 / 7.12
ROE (%) / Sector	67.15 / 42.28 GREAT
ROE Average (%) / Sector	438.83 / 24.22 GREAT
ROE Change Average (%) / Sector	-29.50 / 1.02
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.47
Dividend Average (%) / Sector	N/A / 1.88
Dividend Change Average (%) / Sector	N/A / 6.42

Chi tiết đăng ký

Analyze Date	2026-06-17 09:51:45
Symbol	TRIB
Name	TRINITY BIOTECH PLC
Sector	Healthcare >> Medical Devices
Market	NASDAQ
Listed Shares	20.25 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	13.71 / 18,378.43

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: IDA Business Park, Bray, Ireland, A98 H5C8

Phone: 353 1 276 9800

Website: https://www.trinitybiotech.com

Employees: 287

Sector: Healthcare >> Medical Devices

Description: Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic measurement of haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. In addition, the company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. It serves public health authorities, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. It has a collaboration agreement with a bioinformatics company to conduct analysis on clinical trial data for EpiCapture, a molecular diagnostics company for developing a non invasive urine based prognostic test for progression to aggressive prostate cancer. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.